Skip to content

Randomized placebo Controlled Trial comparing the efficacy of rectal diclofenac, EMLA with a placebo in pain control for hysterosalpingography (HSG).

Pain relief for HSG: A Randomized Controlled Trial comparing the effectiveness of rectal Diclofenac, EMLA and Placebo in pain control during hysterosalpingography (HSG).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201904530885595
Enrollment
90
Registered
2019-04-01
Start date
2018-10-14
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

Rectal diclofenac.
Placebo

Sponsors

National Hospital Abuja
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. All women between the ages of 18 and 49 years undergoing hysterosalpingography as part of their infertility work-up at National Hospital Abuja during the study period. 2. Women already investigated and/or treated for PID. 3. Women with no cervical stenosis or congenital uterine anomaly

Exclusion criteria

Exclusion criteria: 1. Non consenting patients. 2. Patients with active pelvic inflammatory disease 3. Patients with history of any allergy to radiopaque dye, local anaesthetics or anti-inflammatory medications. 4. Patients with previous cervical surgery. 5. Patients younger than 18 years or older than 49 years. 6. Patient who took any form of analgesic within 48 hours before presentation.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be the differences in mean pain scores during the procedure in the three groups.

Secondary

MeasureTime frame
The differences in pain scores at 30minutes and 24 hours after the procedure, level of satisfaction and side effects

Countries

Nigeria

Contacts

Public ContactRukayya M Babandi

Senior Regitrar National Hospital Abuja

rmbabandi@yahoo.com+2348032280518

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026